IP Library Granted Patent US 8,541,372
Granted Patent B2
US 8,541,372 · App. 12/983,350 · Granted Sep 24, 2013

Isolated extracellular matrix material including subserous fascia

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,541,372
App. No.
12/983,350
Granted
Sep 24, 2013
Kind
B2
Abstract

Described are purified extracellular matrix materials isolated from the abdominal wall of animals and including the subserous fascia layer of the abdominal wall. Such medical materials can find use in treating damaged tissue and in certain aspects in providing tissue support for the repair of hernias. Related methods of manufacture and use are also described.

Claims (25)

1. A bioresorbable collagenous and elastinous extracellular matrix graft material having high elasticity and strength, comprising an isolated, bioresorbable layer of highly extensible extracellular matrix material isolated from the abdominal wall of a porcine animal, said extracellular matrix material comprising collagen and elastin and comprising at least the subserous fascia from the abdominal wall, wherein the extracellular matrix material is essentially devoid of native cells, wherein the extracellular matrix material has a tensile strength at break of at least one pound and an elongation at break of at least about 50%, and wherein the extracellular matrix material has a lipid content of less than 15 percent by weight.

2. The graft material of claim 1 , wherein said extracellular matrix material has a lipid content of less than 10 percent by weight.

3. The graft material of claim 1 , wherein said layer also includes parietal peritoneum from the abdominal wall.

4. The graft material of claim 1 , wherein said material is disinfected with an oxidizing disinfectant.

5. The graft material of claim 4 , wherein said oxidizing disinfectant comprises a peroxy compound.

6. The graft material of claim 5 , wherein said peroxy compound is a peracid.

7. The graft material of claim 6 , wherein said peroxy compound is peracetic acid.

8. The graft material of claim 1 , wherein said layer has a length of at least 20 cm and a width of at least 20 cm.

9. The graft material of claim 1 wherein said extracellular matrix material has a lipid content of less than 5 percent by weight.

10. The graft material of claim 1 , comprising at least two said layers bonded to one another.

11. The graft material of claim 10 , also comprising perforations that allow passage of fluid through the graft material.

12. The graft material of claim 10 , wherein said layers are dehydrothermally bonded to one another.

13. The graft material of claim 1 , in a dehydrated form and sealed in sterile condition within a package.

14. A bioresorbable collagenous and elastinous extracellular matrix graft material having high elasticity and strength, comprising an isolated, bioresorbable layer of highly extensible extracellular matrix material isolated from the abdominal wall of a porcine animal, said extracellular matrix material comprising collagen and elastin and comprising at least the subserous fascia from the abdominal wall, wherein the extracellular matrix material is essentially devoid of native cells, wherein the extracellular matrix material has a tensile strength at break of at least one pound and an elongation at break of at least about 50%, and wherein the extracellular matrix material is free from FGF-2.

15. The graft material of claim 14 wherein said extracellular matrix material comprises hyaluronic acid.

16. The graft material of claim 14 wherein said extracellular matrix material has a lipid content of less than 15 percent by weight.

17. The graft material of claim 14 , comprising at least two said layers bonded to one another.

18. A bioresorbable collagenous and elastinous extracellular matrix graft material having high elasticity and strength, comprising two or more isolated, bioresorbable layers of highly extensible extracellular matrix material isolated from the abdominal wall of a porcine animal, wherein said layers are bonded to one another, said extracellular matrix material comprising collagen and elastin and comprising at least the subserous fascia from the abdominal wall, wherein the extracellular matrix material is essentially devoid of native cells, and wherein the extracellular matrix material has a tensile strength at break of at least one pound and an elongation at break of at least about 50%.

19. The graft material of claim 18 wherein said extracellular matrix material has a lipid content of less than 15 percent by weight.

20. The graft material of claim 18 wherein said extracellular matrix material has a lipid content of less than 10 percent by weight.

21. The graft material of claim 18 , also comprising perforations that allow passage of fluid through the graft material.

22. The graft material of claim 18 , wherein said layers are dehydrothermally bonded to one another.

23. The graft material of claim 18 , wherein said layers also include parietal peritoneum from the abdominal wall.

24. The graft material of claim 18 , in a dehydrated form and sealed in sterile condition within a package.

25. The graft material of claim 18 , wherein said layers have a length of at least 20 cm and a width of at least 20 cm.

Assignments (4)
SECURITY INTEREST Recorded Sep 25, 2025
From: RTI SURGICAL, INC.; COOK BIOTECH INCORPORATED; TISSX, LLC
To: GOLUB CAPITAL MARKETS LLC, AS COLLATERAL AGENT
Reel/Frame 072924/0721 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS Recorded Sep 25, 2025
From: ARES CAPITAL CORPORATION
To: COOK BIOTECH INCORPORATED
Reel/Frame 072938/0231 →
SECURITY INTEREST Recorded Apr 3, 2024
From: COOK BIOTECH INCORPORATED
To: ARES CAPITAL CORPORATION, AS SECURITY AGENT
Reel/Frame 067001/0541 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2011
From: SHAH, BHAVIN; HARRIGAN, KATIE L.
To: COOK BIOTECH INCORPORATED
Reel/Frame 025571/0504 →